BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
Clinical trial NCT01903265 · COMPLETED
Trial details
- NCT number
- NCT01903265
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.